m/z |
Oligopeptide structure |
Peptide no. |
Peptide name |
Baltic Sea |
Iznik Lake |
Australian waters |
CCNP 1401 |
CCNP1403 |
B15a |
CCNP1402 |
KAC66 |
BY1 |
CCNP 1423 |
CCNP 1424 |
CCNP 1425 |
Node 2 |
Nodg 3 |
Nodh 2 |
NSBL-05 |
NSBL-06 |
NSLA-01 |
NSOR-02 |
NSGL-01 |
NSKR-07 |
NSBR-01 |
NSPH-02 |
|
Spumigins |
655 |
(Hpla + 42)-Hty-Pro-Arg |
1 |
|
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
653 |
(Hpla + 42)-Hty-MePro-Argal |
2 |
|
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
641 |
(Hpla + 42)-Hty-Pro-Argol |
3 |
|
● |
● |
○ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
639 |
(Hpla + 42)-Hty-Pro-Argal |
4 |
|
● |
● |
● |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
627 |
Hpla-Hty-MePro-Arg |
5 |
B |
◦ |
◦ |
◦ |
◦ |
◦ |
|
|
◦ |
|
◦ |
◦ |
|
|
|
|
|
|
|
|
|
613 |
Hpla-Hty-MePro-Argol |
6 |
A |
○ |
◦ |
◦ |
◦ |
○ |
◦ |
|
|
|
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
613 |
Hpla-Hty-Pro-Arg |
7 |
C |
◦ |
◦ |
◦ |
|
◦ |
|
|
|
|
|
|
|
|
|
◦ |
|
◦ |
|
|
|
611 |
Hpla-Hty-MePro-Argal |
8 |
E |
◦ |
◦ |
◦ |
● |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
599 |
Hpla-Hty-Pro-Argol |
9 |
D |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
○ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
597 |
Hpla-Hty-Pro-Argal |
10 |
F |
○ |
○ |
◦ |
◦ |
○ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
○ |
◦ |
◦ |
◦ |
○ |
◦ |
◦ |
◦ |
595 |
Hpla-Hph-MePro-Argal |
11 |
G |
|
|
|
◦ |
|
○ |
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
|
|
|
583 |
Hpla-Tyr-Pro-Argal |
12 |
|
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
583 |
Hpla-Hty-MePro-Agm |
13 |
|
|
|
|
|
|
|
|
|
|
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
581 |
Hpla-Hph-Pro-Argal |
14* |
H |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
575 |
(Hpla + 42)-Leu-Pro-Argal |
15 |
|
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
535 |
Hpla-Leu-Pro-Argol |
16* |
I |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
470 |
Hpla-Hty-MePro-NH2
|
17 |
|
|
|
|
|
|
|
|
|
|
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
457 |
Hpla-Hty-Pro-OH |
18 |
|
◦ |
◦ |
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aeruginosins |
603 |
-Choi-Arg |
19 |
|
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
|
|
|
|
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
589 |
-Choi-Argol |
20 |
|
◦ |
◦ |
◦ |
○ |
● |
◦ |
|
|
|
○ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
○ |
○ |
◦ |
587 |
-Choi-Argal |
21 |
|
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
● |
● |
● |
● |
● |
● |
● |
◦ |
559 |
-Choi-Agm |
22 |
|
|
|
|
|
|
|
|
|
|
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
|
Nodularins |
825 |
Cyclo[MeAsp-Arg-Adda-Glu-Mdhb] |
23 |
NOD |
● |
● |
● |
● |
● |
● |
○ |
○ |
○ |
● |
● |
● |
● |
|
|
● |
● |
● |
● |
● |
811 |
Cyclo[Asp-Arg-Adda-Glu-Mdhb] |
24 |
[dMeAsp3] |
◦ |
◦ |
◦ |
◦ |
◦ |
◦ |
○ |
○ |
○ |
◦ |
◦ |
◦ |
◦ |
|
|
○ |
◦ |
◦ |
◦ |
● |
|
|
|
NOD |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anabaenopeptins (Nodulapeptins) |
934 |
Phe-CO-[Lys-Val-Hty-MeHty-MetO] |
25 |
|
|
|
|
|
◦ |
|
○ |
○ |
○ |
|
|
|
|
|
|
|
|
|
|
|
932 |
Ile-CO-[Lys-MetO-Hph-MeHty-MetO] |
26 |
|
|
|
|
◦ |
|
◦ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
930 |
Ile-CO-[Lys-MetO2-Hph-MeHty-AcSer] |
27 |
NP A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
918 |
Phe-CO-[Lys-Val-Hph-MeHty-MetO] |
28 |
NP 917 |
|
|
|
|
◦ |
|
○ |
○ |
○ |
|
|
|
|
|
|
|
|
|
|
|
916 |
Ile-CO-[Lys-MetO-Hph-MeHty-Met] |
29 |
|
|
|
|
○ |
|
◦ |
|
|
|
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
916 |
Phe-CO-[Lys-Val-Hty-MeHty-AcSer] |
30 |
|
|
|
|
|
◦ |
|
○ |
○ |
○ |
|
|
|
|
|
|
|
|
|
|
|
914 |
Ile-CO-[Lys-MetO-Hph-MeHty-AcSer] |
31 |
NP B |
|
|
|
● |
|
● |
|
|
|
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
902 |
Phe-CO-[Lys-Val-Hph-MeHty-Met] |
32 |
NP 901 |
|
|
|
|
◦ |
|
○ |
○ |
○ |
|
|
|
|
|
|
|
|
|
|
|
900 |
Phe-CO-[Lys-Val-Hph-MeHty-AcSer] |
33 |
NP 899 |
|
|
|
|
◦ |
|
○ |
○ |
○ |
|
|
|
|
|
|
|
|
|
|
|
900 |
Ile-CO-[Lys-Met-Hph-MeHty-Met] |
34 |
[Met6] |
|
|
|
◦ |
|
◦ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NP C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
898 |
Ile-CO-[Lys-Met-Hph-MeHty-AcSer] |
35 |
NP C |
|
|
|
◦ |
|
○ |
|
|
|
○ |
○ |
◦ |
|
|
|
|
|
|
|
|
898 |
Ile-CO-[Lys-MetO-Hph-MeHph-AcSer] |
36 |
[MeHph5] |
|
|
|
● |
|
○ |
|
|
|
○ |
○ |
○ |
|
|
|
|
|
|
|
|
|
|
|
NP B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
884 |
Ile-CO-[Lys-Met-Hph-MeHph-Met] |
37 |
|
|
|
|
◦ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
884 |
Phe-CO-[Lys-Val-Hph-MeHph-AcSer] |
38 |
|
|
|
|
|
◦ |
|
○ |
○ |
○ |
|
|
|
|
|
|
|
|
|
|
|
882 |
Ile-CO-[Lys-Met-Hph-MeHph-AcSer] |
39 |
|
|
|
|
● |
|
◦ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
882 |
Ile-CO-[Lys-Ile-Hph-MeHty-Met] |
40 |
|
|
|
|
● |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
880 |
Ile-CO-[Lys-Ile-Hph-MeHty-AcSer] |
41 |
|
|
|
|
◦ |
|
◦ |
|
|
|
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
872 |
Ile-CO-[Lys-MetO-Hph-MeHty-Ser] |
42 |
[Ser6] |
|
|
|
◦ |
|
◦ |
|
|
|
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
|
|
|
NP B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
856 |
Ile-CO-[Lys-Met-Hph-MeHty-Ser] |
43 |
|
|
|
|
◦ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
856 |
Ile-CO-[Lys-MetO-Hph-MeHph-Ser] |
44 |
|
|
|
|
◦ |
|
◦ |
|
|
|
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
842 |
Phe-CO-[Lys-Ile-Hty-MeAla-Phe] |
45 |
|
● |
● |
● |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
828 |
Phe-CO-[Lys-Val-Hty-MeAla-Phe] |
46 |
AP D |
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
808 |
Ile-CO-[Lys-Ile-Hty-MeAla-Phe] |
47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
○ |
○ |
◦ |
◦ |
○ |
◦ |
◦ |
◦ |
|
Unknown peptides |
829 |
Unknown |
48 |
|
○ |
○ |
◦ |
|
◦ |
◦ |
|
|
|
◦ |
◦ |
◦ |
|
|
|
|
|
|
|
|
576 |
Unknown |
49 |
|
|
|
|
|
|
|
|
|
|
|
|
|
● |
● |
● |
● |
● |
● |
● |
● |
562 |
Unknown |
50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
◦ |
◦ |
○ |
◦ |
◦ |
◦ |
|
○ |